Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Vaxcyte, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 329
- +66 vs. Q2 2024
- Shares held
- 136.5M
- +23.9M (+21.2%) vs. Q2 2024
- Total value
- $15.6B
- +$7.08B (+83.2%) vs. Q2 2024
- New holders
- 86
- 130 more added
- Sold out
- 20
- 87 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 331 | $9.71B |
| Q1 2026 | 336 | $9.44B |
| Q4 2025 | 295 | $6.81B |
| Q3 2025 | 285 | $5.09B |
| Q2 2025 | 294 | $4.80B |
| Q1 2025 | 315 | $5.88B |
| Q4 2024 | 323 | $11.5B |
| Q3 2024 | 329 | $15.6B |
| Q2 2024 | 265 | $9.26B |
| Q1 2024 | 251 | $8.13B |
| Q4 2023 | 223 | $6.47B |
| Q3 2023 | 202 | $5.17B |
| Q2 2023 | 197 | $5.00B |
| Q1 2023 | 188 | $3.15B |
| Q4 2022 | 198 | $3.91B |
| Q3 2022 | 126 | $1.36B |
| Q2 2022 | 106 | $1.12B |
| Q1 2022 | 88 | $1.20B |
| Q4 2021 | 87 | $1.06B |
| Q3 2021 | 78 | $1.10B |
| Q2 2021 | 75 | $972.7M |
| Q1 2021 | 74 | $869.2M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Vaxcyte, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 15,800,667 | $1.81B | 0.11% | −366,673−2.3% | Reduced |
| Vanguard Group Inc | 11,440,483 | $1.31B | 0.02% | +1,643,488+16.8% | Added |
| Janus Henderson Group PLC | 10,921,896 | $1.25B | 0.64% | +2,052,989+23.1% | Added |
| BlackRock, Inc. | 10,666,437 | $1.22B | 0.03% | +10,666,437 | New |
| Ra Capital Management, L.P. | 8,689,190 | $992.9M | 11.45% | +485,436+5.9% | Added |
| Capital Research Global Investors | 4,898,221 | $559.7M | 0.12% | +764,677+18.5% | Added |
| Wellington Management Group LLP | 4,513,756 | $515.8M | 0.09% | −79,310−1.7% | Reduced |
| Price T Rowe Associates Inc | 4,466,137 | $510.3M | 0.06% | +1,292,970+40.7% | Added |
| T. Rowe Price Investment Management, Inc. | 4,053,828 | $463.2M | 0.28% | +31,239+0.8% | Added |
| State Street Corp | 3,405,743 | $389.2M | 0.02% | +38,596+1.1% | Added |
| Franklin Resources Inc | 2,786,335 | $315.2M | 0.09% | +324,560+13.2% | Added |
| Geode Capital Management, LLC | 2,700,782 | $308.7M | 0.02% | +259,010+10.6% | Added |
| Darwin Global Management, Ltd. | 2,198,187 | $251.2M | 20.43% | +117,241+5.6% | Added |
| Perceptive Advisors LLC | 2,027,608 | $231.7M | 4.97% | +165,000+8.9% | Added |
| Westfield Capital Management Co LP | 1,739,874 | $198.8M | 0.90% | −189,474−9.8% | Reduced |
| Driehaus Capital Management LLC | 1,721,296 | $196.7M | 1.69% | −213,451−11.0% | Reduced |
| Alliancebernstein L.P. | 1,645,914 | $188.1M | 0.06% | −88,907−5.1% | Reduced |
| JPMorgan Chase & Co | 1,427,760 | $163.2M | 0.01% | +215,317+17.8% | Added |
| Invesco Ltd. | 1,312,096 | $149.9M | 0.03% | +233,376+21.6% | Added |
| Charles Schwab Investment Management Inc | 1,295,837 | $148.1M | 0.03% | +419,600+47.9% | Added |
| Fred Alger Management, LLC | 1,243,717 | $142.1M | 0.69% | −66,719−5.1% | Reduced |
| Jennison Associates LLC | 1,237,430 | $141.4M | 0.09% | −145,701−10.5% | Reduced |
| Avoro Capital Advisors LLC | 1,175,000 | $134.3M | 1.96% | +600,000+104.3% | Added |
| Clearbridge Investments, LLC | 1,159,280 | $132.5M | 0.10% | +973,139+522.8% | Added |
| Deutsche Bank AG | 1,148,184 | $131.2M | 0.05% | +1,018,122+782.8% | Added |
| Norges Bank | 1,112,535 | $127.1M | 0.02% | +128,071+13.0% | Added |
| Woodline Partners LP | 1,103,945 | $126.1M | 1.07% | +397,042+56.2% | Added |
| Kynam Capital Management, LP | 1,039,288 | $118.8M | 9.20% | +286,048+38.0% | Added |
| Northern Trust Corp | 1,036,417 | $118.4M | 0.02% | +96,691+10.3% | Added |
| Cormorant Asset Management, LP | 1,000,000 | $114.3M | 6.06% | −100,000−9.1% | Reduced |
| Polar Capital Holdings Plc | 995,779 | $113.8M | 0.67% | +995,779 | New |
| Maverick Capital LtdSuperinvestorMaverick Capital | 976,249 | $111.6M | 2.18% | +288,341+41.9% | Added |
| Goldman Sachs Group Inc | 949,251 | $108.5M | 0.02% | +212,512+28.8% | Added |
| Commodore Capital LP | 920,000 | $105.1M | 6.57% | −385,000−29.5% | Reduced |
| Frazier Life Sciences Management, L.P. | 879,405 | $100.5M | 4.03% | −160,000−15.4% | Reduced |
| Pictet Asset Management Holding SA | 780,905 | $89.2M | 0.10% | +248,001+46.5% | Added |
| Novo Holdings A/S | 750,000 | $85.7M | 4.26% | −200,000−21.1% | Reduced |
| Morgan Stanley | 694,869 | $79.4M | 0.01% | +285,177+69.6% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 639,539 | $73.1M | 43.38% | −153,497−19.4% | Reduced |
| Paradigm Biocapital Advisors LP | 627,732 | $71.7M | 2.51% | +530+0.1% | Added |
| Bank of America Corp | 569,890 | $65.1M | 0.01% | +98,609+20.9% | Added |
| Ensign Peak Advisors, Inc | 546,835 | $62.5M | 0.11% | +84,153+18.2% | Added |
| American Century Companies Inc | 529,005 | $60.4M | 0.04% | +1,411+0.3% | Added |
| Federated Hermes, Inc. | 501,050 | $57.3M | 0.13% | +75,410+17.7% | Added |
| Nuveen Asset Management, LLC | 463,937 | $53.0M | 0.01% | +138,776+42.7% | Added |
| Brown Advisory Inc | 444,039 | $50.7M | 0.06% | +76,822+20.9% | Added |
| Amundi | 434,792 | $48.6M | 0.02% | −7,516−1.7% | Reduced |
| D. E. Shaw & Co., Inc. | 423,498 | $48.4M | 0.06% | +193,291+84.0% | Added |
| Bank of New York Mellon Corp | 412,050 | $47.1M | 0.01% | −56,529−12.1% | Reduced |
| UBS Asset Management Americas Inc | 408,274 | $46.7M | 0.01% | +112,512+38.0% | Added |
| OrbiMed Advisors LLC | 387,000 | $44.2M | 0.81% | −408,900−51.4% | Reduced |
| Eventide Asset Management, LLC | 383,454 | $43.8M | 0.76% | −355,699−48.1% | Reduced |
| TD Asset Management Inc | 366,156 | $41.4M | 0.04% | +53,730+17.2% | Added |
| Point72 Asset Management, L.P. | 359,796 | $41.1M | 0.14% | +359,796 | New |
| EcoR1 Capital, LLC | 352,464 | $40.3M | 1.38% | +52,464+17.5% | Added |
| Ameriprise Financial Inc | 350,151 | $40.0M | 0.01% | +72,387+26.1% | Added |
| Allspring Global Investments Holdings, LLC | 347,474 | $39.7M | 0.06% | +3,922+1.1% | Added |
| Cercano Management LLC | 327,742 | $37.5M | 0.90% | +54,134+19.8% | Added |
| Lord, Abbett & Co. LLC | 312,425 | $35.7M | 0.11% | +66,183+26.9% | Added |
| Voya Investment Management LLC | 303,879 | $34.7M | 0.04% | +15,873+5.5% | Added |
| Tang Capital Management LLC | 300,000 | $34.3M | 2.45% | 00.0% | Unchanged |
| Logos Global Management LP | 300,000 | $34.3M | 3.84% | +300,000 | New |
| Siren, L.L.C. | 299,991 | $34.3M | 1.72% | +299,991 | New |
| Millennium Management LLC | 298,435 | $34.1M | 0.03% | +94,704+46.5% | Added |
| Braidwell LP | 297,568 | $34.0M | 0.96% | −510,735−63.2% | Reduced |
| Comerica Bank | 273,022 | $31.2M | 0.12% | −30.0% | Reduced |
| Tri Locum Partners LP | 271,922 | $31.1M | 7.44% | +158,578+139.9% | Added |
| TimesSquare Capital Management, LLC | 269,121 | $30.8M | 0.46% | +269,121 | New |
| Victory Capital Management Inc | 255,040 | $29.1M | 0.03% | −52,476−17.1% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 225,000 | $25.7M | 0.38% | +225,000 | New |
| Voloridge Investment Management, LLC | 224,446 | $25.6M | 0.09% | +224,446 | New |
| Citigroup Inc | 220,543 | $25.2M | 0.02% | +54,748+33.0% | Added |
| Alyeska Investment Group, L.P. | 218,831 | $25.0M | 0.13% | +218,831 | New |
| First Turn Management, LLC | 211,985 | $24.2M | 3.84% | −48,296−18.6% | Reduced |
| Barclays PLC | 209,753 | $24.0M | 0.01% | +81,801+63.9% | Added |
| Macquarie Group Ltd | 208,875 | $23.9M | 0.03% | +49,863+31.4% | Added |
| Saturn V Capital Management LLC | 204,987 | $23.4M | 8.37% | −10,693−5.0% | Reduced |
| California Public Employees Retirement System | 195,086 | $22.3M | 0.02% | +42,308+27.7% | Added |
| Swiss National Bank | 180,600 | $20.6M | 0.01% | −700−0.4% | Reduced |
| SEI Investments Co | 179,217 | $20.5M | 0.03% | +9,068+5.3% | Added |
| Eagle Asset Management Inc | 176,249 | $18.8M | 0.10% | −106,102−37.6% | Reduced |
| Rhumbline Advisers | 164,103 | $18.8M | 0.02% | +4,808+3.0% | Added |
| Manufacturers Life Insurance Company, The | 157,024 | $17.9M | 0.02% | +25,275+19.2% | Added |
| Segall Bryant & Hamill, LLC | 156,056 | $17.8M | 0.24% | −6,376−3.9% | Reduced |
| WCM Investment Management, LLC | 140,847 | $15.9M | 0.04% | +48,543+52.6% | Added |
| Dimensional Fund Advisors LP | 136,429 | $15.6M | 0.00% | +100,787+282.8% | Added |
| Acuta Capital Partners, LLC | 135,400 | $15.5M | 12.53% | +25,000+22.6% | Added |
| Parkman Healthcare Partners LLC | 130,249 | $14.9M | 1.90% | −19,942−13.3% | Reduced |
| Maven Securities LTD | 129,700 | $14.8M | 1.67% | +129,700 | New |
| First Trust Advisors LP | 117,864 | $13.5M | 0.01% | +38,938+49.3% | Added |
| UBS Group AG | 111,573 | $12.7M | 0.00% | +15,897+16.6% | Added |
| Legal & General Group Plc | 99,528 | $11.4M | 0.00% | +3,218+3.3% | Added |
| Prudential Financial Inc | 96,653 | $11.0M | 0.02% | +15,315+18.8% | Added |
| California State Teachers Retirement System | 89,436 | $10.2M | 0.01% | −1,843−2.0% | Reduced |
| Jane Street Group, LLC | 85,543 | $9.77M | 0.02% | −21,068−19.8% | Reduced |
| Opaleye Management Inc. | 85,000 | $9.71M | 1.62% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 82,830 | $9.46M | 0.02% | −107,571−56.5% | Reduced |
| Neuberger Berman Group LLC | 82,733 | $9.45M | 0.01% | −25,359−23.5% | Reduced |
| Nicholas Investment Partners, LP | 81,883 | $9.36M | 0.86% | −5,347−6.1% | Reduced |
| Raymond James & Associates | 81,235 | $9.28M | 0.01% | +11,798+17.0% | Added |